Today on TAP: After an FDA finding that a popular decongestant is worthless, Biden could direct that agency to fast-track approval of a miracle drug for colds used all over the world.
prescription drugs
Posted inHealth and Social Policy
We May Not Negotiate Prices for Ten Drugs After All
Rules that exempt drugs from Medicare negotiation if there’s ‘meaningful’ generic competition could whittle down the effect of the program.
Posted inTAP
Biden Takes First Step Toward Making Marijuana ‘A Little Less Illegal’
Today on TAP: The Health and Human Services Department recommends loosening federal restrictions on cannabis.
Posted inHealth and Social Policy
Medicare Price Negotiation: Ten Drugs That Made the List, and Ten That Should Have
Advocates were thrilled that Medicare will negotiate the price of several insulins. But other high-profit drugs are protected by the new program’s rules.
Posted inHealth and Social Policy
Pricing a Lifesaving Drug
Will Medicare use its ample leverage to make Wegovy affordable?
Posted inMoney, Politics, and Power
Who’s Running Big Pharma’s Last Stand Against Slightly Fairer Drug Pricing
One year after IRA passage, bad actors try to thwart drug price negotiation, and Biden’s efforts to defend it fall short.
Posted inTAP
Eminent Domain for Overpriced Drugs
Today on TAP: Exhibit A is the case of the EpiPen. It should cost a few dollars rather than the $600 or more charged by monopolist Viatris.
Posted inHealth and Social Policy
Gatekeeper of the Gougers
In a newly unsealed deposition, a former Express Scripts executive (unintentionally) reveals how hard his colleagues were undermining his ‘mission’ to cut drug prices.
Posted inHealth and Social Policy
The Oliver Twist
How orphan drugs became big business for Big Pharma
Posted inHealth and Social Policy
Pharma Giants Block Access to Vaccine Doses for Research
Pfizer and Moderna are preventing scientists from using their current vaccines for research. The U.S. should act now to restore competition.